Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMC 414649)

Published in Infect Immun on November 01, 1979

Authors

W E Brandt, J M McCown, F H Top, W H Bancroft, P K Russell

Articles citing this

Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun (1982) 1.69

Dengue-2 vaccine: preparation from a small-plaque virus clone. Infect Immun (1980) 1.67

Demonstration of binding of dengue virus envelope protein to target cells. J Virol (1996) 1.60

Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immun (1981) 1.58

Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol (1997) 1.49

Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients. Infect Immun (1981) 1.28

Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol (2002) 1.25

Dengue virus selectively induces human mast cell chemokine production. J Virol (2002) 1.12

Effects of antibody isotype and host cell type on in vitro neutralization of Chlamydia trachomatis. Infect Immun (1993) 0.99

Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection. Infect Immun (1997) 0.95

In vitro virulence marker: growth of dengue-2 virus in human leukocyte suspension cultures. Infect Immun (1981) 0.86

Lack of greater seroconversion of rhesus monkeys after subcutaneous inoculation of dengue type 2 live-virus vaccine combined with infection-enhancing antibodies. Infect Immun (1981) 0.85

Temperature-sensitive events during the replication of the attenuated S-1 clone of dengue type 2 virus. Infect Immun (1983) 0.80

Enhancement of dengue virus type 2 replication in mouse macrophage cultures by bacterial cell walls, peptidoglycans, and a polymer of peptidoglycan subunits. Infect Immun (1983) 0.76

The Cellular Bases of Antibody Responses during Dengue Virus Infection. Front Immunol (2016) 0.75

The citrus flavanone naringenin impairs dengue virus replication in human cells. Sci Rep (2017) 0.75

Articles cited by this

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med (1977) 7.01

Activation of mononuclear phagocytes: fact, fancy, and future. J Immunol (1978) 6.22

Antibody-enhanced dengue virus infection in primate leukocytes. Nature (1977) 4.18

Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med (1977) 2.84

Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect Immun (1976) 2.67

Immunological enhancement of dengue virus replication. Nat New Biol (1973) 2.61

Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol (1976) 1.79

Dengue virus replication enhancement in peripheral blood leukocytes from immune human beings. Proc Soc Exp Biol Med (1976) 1.60

Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates. Infect Immun (1977) 1.51

Replication of dengue viruses in cultures of peripheral blood leukocytes from dengue-immune rhesus monkeys. J Infect Dis (1976) 1.49

Dengue carrier culture and antigen production in human lymphoblastoid lines. Intervirology (1975) 1.37

Selective clearance of a benign clone of Venezuelan equine encephalitis virus from hamster plasma by hepatic reticuloendothelial cells. J Infect Dis (1975) 1.24

Chromatographic separations of alphavirus strains by hydroxylapatite. J Clin Microbiol (1977) 0.96

Phytohemagglutinin enhancement of dengue-2 virus replication in nonimmune rhesus monkey peripheral blood leukocytes. Infect Immun (1978) 0.89

Articles by these authors

Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23

Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45

Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96

Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06

Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol (1989) 7.06

A plaque reduction test for dengue virus neutralizing antibodies. J Immunol (1967) 5.78

Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg (1989) 4.79

Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg (1982) 4.04

Flaviviridae. Intervirology (1985) 3.06

Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis (1971) 2.83

Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect Immun (1976) 2.67

The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med (1973) 2.64

Production and characterization of arbovirus antibody in mouse ascitic fluid. Am J Trop Med Hyg (1967) 2.61

Detection of additional antigenic determinants of hepatitis B antigen. J Immunol (1972) 2.57

Bunyaviridae. Intervirology (1980) 2.53

Dengue virus identification by the plaque reduction neutralization test. J Immunol (1967) 2.45

Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am J Trop Med Hyg (1982) 2.41

M antigens among group A streptococci isolated from skin lesions. J Exp Med (1967) 2.35

Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing. Virology (1976) 2.32

Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am J Trop Med Hyg (1985) 2.04

Prevention of endemic HAA-positive hepatitis with gamma globulin. Use of a simple radioimmune assay to detect HAA. N Engl J Med (1972) 2.00

Togaviridae. Intervirology (1985) 1.96

Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. Am J Trop Med Hyg (1983) 1.96

Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis (1971) 1.95

Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol (1967) 1.94

Swine influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and speculation. J Infect Dis (1977) 1.88

Measles in Detroit, 1935 -I, Factors Influencing the Secondary Attack Rate Among Susceptibles at Risk. Am J Public Health Nations Health (1938) 1.86

Interaction of Sindbis virus with liposomal model membranes. J Virol (1975) 1.85

Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. Am J Trop Med Hyg (1968) 1.80

Specific immunoglobulin M response to hepatitis A virus determined by solid-phase radioimmunoassay. Infect Immun (1980) 1.79

Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol (1976) 1.79

Physical and biological properties of dengue-2 virus and associated antigens. J Virol (1970) 1.75

A Small Outbreak of Smallpox in Detroit. Am J Public Health Nations Health (1943) 1.71

Radioimmune precipitation of group A arboviruses. J Immunol (1972) 1.71

Immunoprecipitation analysis of soluble complement-fixing antigens of dengue viruses. J Immunol (1970) 1.69

Change involving a viral membrane glycoprotein during morphogenesis of group B arboviruses. Virology (1972) 1.69

Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun (1982) 1.69

An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies. Am J Trop Med Hyg (1968) 1.68

Dengue-2 vaccine: preparation from a small-plaque virus clone. Infect Immun (1980) 1.67

Immunological and biophysical separation of dengue-2 antigens. J Virol (1971) 1.66

Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Virol (1984) 1.66

Fatal pneumonia associated with adenovirus type 7 in three military trainees. N Engl J Med (1972) 1.64

Anti-dengue immunoglobulins and serum beta 1 c-a globulin levels in dengue shock syndrome. J Immunol (1969) 1.64

The proteins of Japanese encephalitis virus. Virology (1971) 1.63

Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group. Pediatr Infect Dis J (1998) 1.63

An analysis of fevers of unknown origin in American soldiers in Vietnam. Ann Intern Med (1967) 1.61

Primary isolation and serial passage of hepatitis A virus strains in primate cell cultures. J Clin Microbiol (1984) 1.61

Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol (1989) 1.59

Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immun (1981) 1.58

Bunyaviruses and Bunyaviridae. Intervirology (1976) 1.58

Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates. Infect Immun (1977) 1.51

Pathogenesis of renal disease associated with viral hepatitis. Arch Pathol (1974) 1.48

Antibody response in dengue and dengue hemorrhagic fever. Jpn J Med Sci Biol (1967) 1.47

Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J Infect Dis (1977) 1.46

MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol (1999) 1.44

The serum opacity reaction of Streptococcus pyogenes. The demonstration of multiple, strain-specific lipoproteinase antigens. J Exp Med (1968) 1.43

Human leptospirosis acquired from squirrels. N Engl J Med (1967) 1.42

Epidemiology of Poliomyelitis in Detroit in 1939. Am J Public Health Nations Health (1941) 1.40

Experimental infection of chimpanzees with dengue viruses. Am J Trop Med Hyg (1978) 1.39

Swine influenza A at Fort Dix, New Jersey (January-February 1976). I. Case finding and clinical study of cases. J Infect Dis (1977) 1.39

Shock syndrome in primary dengue infections. Am J Trop Med Hyg (1976) 1.38

Swine influenza A at Fort Dix, New Jersey (January-February 1976). III. Extent of spread and duration of the outbreak. J Infect Dis (1977) 1.38

The serum opacity reaction of Streptococcus pyogenes: frequency of production of streptococcal lipoproteinase by strains of different serological types and the relationship of M protein production. J Hyg (Lond) (1968) 1.38

Non-A, non-B hepatitis and antibody to hepatitis C virus. JAMA (1990) 1.37

Partial purification and characterization of a dengue virus soluble complement-fixing antigen. J Immunol (1970) 1.37

Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation. J Infect Dis (1988) 1.37

Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines. Am J Epidemiol (1971) 1.36

Experimental transmission of hepatitis B virus by semen and saliva. J Infect Dis (1980) 1.35

Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group. J Pediatr (1998) 1.34

Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). Am J Trop Med Hyg (1970) 1.33

Control of adenovirus acute respiratory disease in U.S. Army trainees. Yale J Biol Med (1975) 1.33

Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis (1971) 1.33

Antigenic components of group A arbovirus virions. J Virol (1973) 1.30